ATE390435T1 - Zusammensetzungen und verfahren zur diagnose und behandlung von diabetes, insulinresistenz und dyslipidämie - Google Patents
Zusammensetzungen und verfahren zur diagnose und behandlung von diabetes, insulinresistenz und dyslipidämieInfo
- Publication number
- ATE390435T1 ATE390435T1 AT02795910T AT02795910T ATE390435T1 AT E390435 T1 ATE390435 T1 AT E390435T1 AT 02795910 T AT02795910 T AT 02795910T AT 02795910 T AT02795910 T AT 02795910T AT E390435 T1 ATE390435 T1 AT E390435T1
- Authority
- AT
- Austria
- Prior art keywords
- methods
- diabetes
- dyslipidemia
- insulin resistance
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34145101P | 2001-12-17 | 2001-12-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE390435T1 true ATE390435T1 (de) | 2008-04-15 |
Family
ID=23337630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02795910T ATE390435T1 (de) | 2001-12-17 | 2002-12-16 | Zusammensetzungen und verfahren zur diagnose und behandlung von diabetes, insulinresistenz und dyslipidämie |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7510851B2 (de) |
| EP (1) | EP1465911B1 (de) |
| JP (1) | JP2005520497A (de) |
| AT (1) | ATE390435T1 (de) |
| AU (1) | AU2002360637B2 (de) |
| CA (1) | CA2470431A1 (de) |
| DE (1) | DE60225845D1 (de) |
| WO (1) | WO2003051182A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7054758B2 (en) | 2001-01-30 | 2006-05-30 | Sciona Limited | Computer-assisted means for assessing lifestyle risk factors |
| WO2007127965A1 (en) * | 2006-04-28 | 2007-11-08 | Mayo Foundation For Medical Education And Research | Treating glaucoma, cardiovascular diseases, and renal diseases |
| JP5283106B2 (ja) * | 2008-03-14 | 2013-09-04 | 国立大学法人 熊本大学 | C型肝炎ウイルス阻害剤 |
| NZ603816A (en) * | 2010-05-27 | 2014-06-27 | Pharmazell Gmbh | Novel 7alpha-hydroxysteroid dehydrogenase knockout mutants and use thereof |
| BR112023017989A2 (pt) * | 2021-03-05 | 2023-12-12 | Ascentawits Pharmaceuticals Ltd | Composição de primer-sonda, kit, e método de detecção |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60142984A (ja) * | 1983-12-28 | 1985-07-29 | Kyorin Pharmaceut Co Ltd | 新規なスピロピロリジン−2,5−ジオン誘導体およびその製造法 |
| US6124115A (en) | 1995-09-22 | 2000-09-26 | Endorecherche Inc. | Production and use of isolated type 5 17β-hydroxysteroid dehydrogenase |
| US5756299A (en) * | 1996-12-09 | 1998-05-26 | Incyte Pharmaceuticals, Inc. | Human carbonyl reductase |
| US6001353A (en) * | 1997-05-09 | 1999-12-14 | The Board Of Trustees Of The Univeristy Of Illinois | 20α-alpha-hydroxy steroid dehydrogenase related material and methods |
| AU765214B2 (en) * | 1998-05-06 | 2003-09-11 | Metamorphix International, Inc. | Methods for treating diabetes by inhibiting gdf-8 |
| AU2001255330A1 (en) * | 2000-04-12 | 2001-10-30 | Genaissance Pharmaceuticals, Inc. | Haplotypes of the akr1b1 gene |
| WO2002053704A2 (en) * | 2001-01-04 | 2002-07-11 | Myriad Genetics, Inc. | Protein-protein interactions |
| KR100423912B1 (ko) | 2001-05-04 | 2004-03-24 | 삼성전자주식회사 | 씨모스형 반도체 장치 형성 방법 |
-
2002
- 2002-12-16 AU AU2002360637A patent/AU2002360637B2/en not_active Ceased
- 2002-12-16 EP EP02795910A patent/EP1465911B1/de not_active Expired - Lifetime
- 2002-12-16 CA CA002470431A patent/CA2470431A1/en not_active Abandoned
- 2002-12-16 US US10/321,204 patent/US7510851B2/en not_active Expired - Fee Related
- 2002-12-16 AT AT02795910T patent/ATE390435T1/de not_active IP Right Cessation
- 2002-12-16 WO PCT/US2002/040397 patent/WO2003051182A2/en not_active Ceased
- 2002-12-16 JP JP2003552120A patent/JP2005520497A/ja active Pending
- 2002-12-16 DE DE60225845T patent/DE60225845D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE60225845D1 (de) | 2008-05-08 |
| EP1465911A2 (de) | 2004-10-13 |
| US7510851B2 (en) | 2009-03-31 |
| EP1465911B1 (de) | 2008-03-26 |
| WO2003051182A3 (en) | 2004-08-12 |
| US20030186871A1 (en) | 2003-10-02 |
| WO2003051182A2 (en) | 2003-06-26 |
| CA2470431A1 (en) | 2003-06-26 |
| JP2005520497A (ja) | 2005-07-14 |
| EP1465911A4 (de) | 2006-04-19 |
| AU2002360637A1 (en) | 2003-06-30 |
| AU2002360637B2 (en) | 2007-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE440536T1 (de) | Verfahren zur diagnose, behandlung und prävention von knochenverlust | |
| ATE488251T1 (de) | Verfahren zur diagnose und behandlung von schwangerschaftsskomplikationen | |
| BR0111125A (pt) | Moléculas de ácido nucléico de nrg-2, polipeptìdeos, e métodos diagnóstico e terapêuticos | |
| DE60325617D1 (de) | Verfahren zur diagnose von bauchspeicheldrüsenkrebs | |
| ATE453653T1 (de) | Platinkomplexe zur behandlung von tumoren | |
| ATE321570T1 (de) | Verfahren zur behandlung von hämostatischen störungen durch lösliches p-selectin | |
| DE60236206D1 (de) | Spiroazacyclische verbindungen als monoaminrezeptormodulatoren | |
| EP1550462A4 (de) | MITTEL ZUR BEHANDLUNG ODER PRûVENTION VON NIERENERKRANKUNGEN UND VERFAHREN ZUR DIAGNOSE VON NIERENERKRANKUNGEN | |
| ATE352311T1 (de) | Verwendung von brustkrebs membranproteine für behandlung, prophylaxe und diagnose von brustkrebs | |
| ATE356995T1 (de) | Verfahren zur identifizierung von mitteln zur behandlung von diabetes | |
| ATE338142T1 (de) | Methoden zur diagnose und behandlung von herzkrankheiten | |
| ATE480641T1 (de) | Zusammensetzungen, reagenzien, kits und verfahren für die diagnose und behandlung von fettleibigkeit und/oder diabetes | |
| DE60225845D1 (de) | Zusammensetzungen und verfahren zur diagnose und behandlung von diabetes, insulinresistenz und dyslipidämie | |
| WO2003101284A3 (en) | Methods of diagnosing and treating diabetes and insulin resistance | |
| WO2006017171A3 (en) | Methods of diagnosing & treating obesity, diabetes and insulin resistance | |
| ATE393785T1 (de) | Glykopeptide, deren herstellung und verwendung in der diagnose oder behandlung von multipler sklerose | |
| EP1363528A4 (de) | Verfahren zur diagnose und behandlung von herzerkrankungen | |
| WO2003102161A3 (en) | Methods of diagnosing & treating diabetes and insulin resistance | |
| WO2003103601A3 (en) | Methods of diagnosing & treating diabetes and insulin resistance | |
| ATE554790T1 (de) | Verfahren und zusammensetzungen zur diagnose von asthma | |
| ATE363075T1 (de) | Verfahren zur diagnose und behandlung von metastasen und dafür nützliche zusammensetzung | |
| EP1370697A4 (de) | Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion und verfahren zu deren verwendung | |
| WO2004019875A3 (en) | Non-invasive methods to identify agents for treating pain | |
| DE60135339D1 (de) | Behandlungsverfahren unter verwendung von 17906 und dessen anwendungen | |
| WO2006010051A3 (en) | Methods of diagnosing & treating diabetes and insulin resistance |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |